These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 18672491)
1. U.S. Food and Drug Administration and off-label use of expandable metal biliary stents within the peripheral vasculature. Yustein AS; Schultz D; Neuland C; Buckles DS; Nipper JC; Stephenson RA; Gonzalez G J Vasc Interv Radiol; 2008 Jul; 19(7):965-9. PubMed ID: 18672491 [TBL] [Abstract][Full Text] [Related]
2. Off-label does not mean off-base. Kaufman JA J Vasc Interv Radiol; 2008 Jul; 19(7):970-1. PubMed ID: 18589309 [No Abstract] [Full Text] [Related]
3. US Food and Drug Administration and Off-Label Use of Metal Expandable Biliary Stents within the Peripheral Vasculature-Update. Marrone AK; Gottschalk L; Chen AL J Vasc Interv Radiol; 2020 Apr; 31(4):622-628. PubMed ID: 32094048 [TBL] [Abstract][Full Text] [Related]
4. The "art" of medicine and the "smokescreen" of the randomized trial off-label use of vascular devices. Ansel GM; Jaff MR Catheter Cardiovasc Interv; 2008 Dec; 72(7):998-1002. PubMed ID: 19021289 [TBL] [Abstract][Full Text] [Related]
5. Malfunctions and adverse events associated with off-label use of biliary stents in the peripheral vasculature. Bridges J; Maisel WH Am J Ther; 2008; 15(1):12-8. PubMed ID: 18223348 [TBL] [Abstract][Full Text] [Related]
7. The "criminalization" of off-label device use. White CJ Catheter Cardiovasc Interv; 2008 Oct; 72(4):588-9. PubMed ID: 18819154 [No Abstract] [Full Text] [Related]
8. Regulatory approval of peripheral endovascular revascularization devices in the United States: is the horse still in the barn? Weinberger J; Rundback JH; Ratchford EV Am J Ther; 2005; 12(2):186-91. PubMed ID: 15767839 [TBL] [Abstract][Full Text] [Related]
9. Off-label use of medical devices in radiology: regulatory standards and recent developments. Smith JJ J Am Coll Radiol; 2010; 7(2):115-9. PubMed ID: 20142085 [TBL] [Abstract][Full Text] [Related]
10. Medical-device safety and the FDA. Schultz DG N Engl J Med; 2008 Jul; 359(1):88-9; author reply 89. PubMed ID: 18596278 [No Abstract] [Full Text] [Related]
11. Preliminary results of a new covered biliary metal stent for malignant biliary obstruction. Shim CS; Lee YH; Cho YD; Bong HK; Kim JO; Cho JY; Kim YS; Lee JS; Lee MS; Hwang SG; Shin KM Endoscopy; 1998 May; 30(4):345-50. PubMed ID: 9689506 [TBL] [Abstract][Full Text] [Related]
12. Premarket assessment of devices for treatment of critical limb ischemia: the role of Objective Performance Criteria and Goals. Geraghty PJ; Matsumura JS; Conte MS J Vasc Surg; 2009 Dec; 50(6):1459-61. PubMed ID: 19897333 [TBL] [Abstract][Full Text] [Related]
13. Anchoring flap versus flared end, fully covered self-expandable metal stents to prevent migration in patients with benign biliary strictures: a multicenter, prospective, comparative pilot study (with videos). Park DH; Lee SS; Lee TH; Ryu CH; Kim HJ; Seo DW; Park SH; Lee SK; Kim MH; Kim SJ Gastrointest Endosc; 2011 Jan; 73(1):64-70. PubMed ID: 21184871 [TBL] [Abstract][Full Text] [Related]
14. An overview of FDA medical device regulation as it relates to deep brain stimulation devices. Peña C; Bowsher K; Costello A; De Luca R; Doll S; Li K; Schroeder M; Stevens T IEEE Trans Neural Syst Rehabil Eng; 2007 Sep; 15(3):421-4. PubMed ID: 17894274 [TBL] [Abstract][Full Text] [Related]